SecureDocs Blog Q1 M&A: Running Against the Wind

Q1 was a tough quarter for M&A, continuing a trend of softening sentiment thanks to high interest rates, supply chain challenges, and recession fears. Globally, there were just under 6,000 deals, down about 30% from Q1. Total deal value was down 40% to $775 billion. A rare bright spot was the Life Sciences sector, which saw an increase in total deal value, largely due to mega-mergers ranging from healthcare systems to Big Pharma. There are a number of real headwinds facing markets, but several emerging trends could support economic activity moving forward.